Hormone replacement therapy: Relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 733-739

  Gökkuou, Cahide ^a   Özbek, Zeynep ^b   Tata, Gülten ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Eyup State Hospital   (Turkey)

Author keywords

Homocysteine; Menopause; Oxidant and antioxidant status

Indexed keywords

CARBONYL DERIVATIVE; CHOLESTEROL; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL; FOLLITROPIN; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; MALONALDEHYDE; PLACEBO; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; CYPROTERONE ACETATE; DRUG DERIVATIVE; ESTRADIOL VALERATE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; RISK REDUCTION; TREATMENT OUTCOME; BLOOD; DRUG EFFECT; ESTROGEN THERAPY; MIDDLE AGED;

ADULT; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; HUMANS; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 84863202392     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2051-2     Document Type: Article

References (44)

1. Marchesoni D, Driul L, Plaino L, Villani MT, Becagli L, Mozanega B (2003) Menopause rather than estrogen modiWes plasma homocysteine levels. Int J Gynecol Obstet 81:293-297.
2. Jung K, Kim S, Jeongik W, Chang Y (2002) The eVect of dietary intervention through the modiWcation of fatty acids composition and antioxidant vitamin intake on plasma TxB2 level Korean postmenopausal women with hypercholesterolemia. J Korean Med Sci 17:307-315.
3. Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ (1999) EVects of menopause and hormone replacement therapy on plasma lipids, lipoprteins and LDL-receptor activity. Maturitas 33:259-269.
4. Kannel WB, Hjortland MC, Mc Namara PM, Gordon T (1976) Menopause and risk of cardio-vascular disease: the Framingham study. Ann Intern Med 85:447-452.
5. Peters HWW, Westendorp ICD, Hak AE, Grobbee DE, Stehouwer CDA, Hofman A et al (1999) Menopausal status and risk factors for cardiovascular disease. J Intern Med 246:521-528.
6. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J et al (2007) WHI and WHI-CACS investigators. Estrogen therapy and coronary-artery calciWcation. N Engl J Med 297:1465-1477.
7. Bar J, Tepper R, Fucs J, Pardo Y, Goldberger S, Ovadia J (1993) The eVect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 81:261-264.
8. Rosano GMC, MaVei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M et al (2009) Hormone replacement therapy and cardioprotection: a new dawn? A statement of the study group on cardiovascular disease in women of the Italian Society of cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med 10:85-92.
9. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465-1477.
10. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J et al (2007) WHI and WHI-CACS investigators. Estrogen therapy and coronary-artery calciWcation. N Engl J Med 356:2591-2602.
11. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C et al (2001) Oxidative stress and homocysteine in coronary artery disease. Clin Chem 47:887-892.
12. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D et al (1993) Adverse vascular eVects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318.
13. Mijatovic V, van der Mooren MJ (2001) Homocysteine in postmenopausal women and the importance of hormone replacement therapy. Clin Chem Lab Med 39:764-767.
14. Hak AE, Polderman KH, Westendorp IC, Iakobs C, Hofman A, WÂtteman IC et al (2000) Increased plasma homocysteine after menopause. Atherosclerosis. 149:163-168.
15. Madsen JS, Kristensen SR, Klitgaard NA, Bladbjerg EM, Abrahamsen B, Stilgen L et al (2002) EVect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am J Obstet Gynecol 187:33-39.
16. Bureau I, Laporte F, Favier M, Faure H, Fiels M, Favier AE et al (2002) No antioxidant eVect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 21:333-338.
17. Castelao JE, Gago-Dominquez M (2008) Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 71:39-44.
18. Gokkuou C, Tata G, Ademoglu E, Tamer S (2010) The beneWts of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women. Platelets 21:439-444.
19. Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF (2000) Hormone replacement therapy for oxidative stress in postmenopausal women with hot Xushes. Obstet Gynecol 95:804-809.
20. Clemente C, Carusa MG, Berloco P, Notarnicola M, D'Attoma B, Osella AR et al (1999) Antioxidant eVect of short-term hormonal treatment in postmenopausal women. Maturitas 31:137-142.
21. Mittal PC, Kant R (2009) Correlation of increased oxidative stress to body weight in disease-free postmenopausal women. Clin Biochem 42:1007-1011.
22. Jha R, Rizvi SI (2011) Carbonyl formation in erythrocyte membrane proteins during aging in humans. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155:39-42.
23. Bagatini MD, Martins CC, Battisti V, Gasparetto D, da Rosa CS, Spanevello RM et al (2011) Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels 26:55-63.
24. Oh JM, Kim SH, Suh CH, Nahm DH, Park HS, Lee YM et al (2005) Lack of association of glutathione S-transferase P1Ile105Val polymorphism with aspirin-intolerant asthma. Korean J Int Med 20:232-236.
25. Darabi M, Ani M, Movahedian A, Zarean E, Panjehpour M, Rabbani M (2010) EVect of hormone replacement therapy on total serum anti-oxidant potential and oxidized LDL/ß2-glycoprotein I complexes in postmenopausal women. Endocr J 57:1029-1034.
26. Leino A (1999) Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMX analyzer. Clin Chem 91:308-318.
27. Wasowicz W, Neve J, Peretz A (1993) Optimized steps in Xuorometric determination of thiobarbituric acid-reactive substance in serum: importance of extraction pH and inXuence of sample preservation and storage. Clin Chem 39:2522-2526.
28. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:359-363.
29. Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Method Enzymol 233:380-385.
30. Sun Y, Oberley LW (1994) Suitability of cooper chloride as a reaction terminator superoxide dismutase activity assay. Clin Chim Acta 226:101-103.
31. Habig WH, Jakoby WB (1981) Assay for diVerentiation of glutathione S-transferases. Method Enzymol 77:398-405.
32. Smolders RGV, van der Mooren MJ, Teerlink T, Merkus JMWM, Kroeks MVAM, Franke HR et al (2003) A randomized placebocontrolled study of the eVect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril 79:261-267.
33. Nielsen NE, Brattström L, Hultberg B, Landgren F, Swahn E (2000) Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease. Atherosclerosis 151:423-431.
34. Christodoulakos G, Panoulis C, Rizos D, Moustakarias T, Phocas I, Creatsas G (2001) Homocysteine and folate levels in postmenopausal women. Maturitas 39:161-167.
35. De la Calle M, Usandizaga R, Sancha M, Magdaleno F, Herranz A, Cabrillo E (2003) Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 107:125-134.
36. Farag NH, Barshop BA, Mills PJ (2003) EVects of estrogen and psychological stress on plasma homocysteine levels. Fertil Steril 7:256-260.
37. Mutlu-Turkoglu U, Ilhan E, Oztezcan S, Kuru A, Aykac-Toker G, Uysal M (2003) Age-related increase in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 36:397-400.
38. Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G et al (2006) Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53:77-82.
39. Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B et al (2004) Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 19:57-63.
40. Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R (2001) Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and, postmenopausal women. Gynecol Endocrinol 15:298-303.
41. Genc S, Gurdol F, Oner-Iyidogan Y, Suzme R (1999) Acute eVects of estradiol and of DES: Pro-or antioxidant potency? Res Commun Molec Pathol Pharmacol 105:253-261.
42. Ruiz-Larrea MB, Garrido J, Locart M (1993) Estradiol-induced eVects on glutathione metabolism in rat hepatocytes. J Biochem 113:563-567.
43. Knapen MFCM, Zusterzeel PLM, Peters WHM, Steegers EAP (1999) Glutathione and glutathione-related enzymes in reproduction. Eur J Obstet Gyn RB 82:171-184.
44. Mulder TPJ, Knapen FCM, Van der Mooren MJ, Demacker PD, Roes EM, Steegers EAP et al (1998) EVects of hormone replacement therapy on plasma glutathione s-transferase-1-1 concentrations in healthy postmenopausal women. Clin Chem 44:666-667